NRx Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
29
- Stock Symbol
-
NRXP
- Investments
-
3
- Share Price
-
$2.27
- (As of Thursday Closing)
NRx Pharmaceuticals General Information
Description
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Contact Information
Website
www.nrxpharma.comCorporate Office
- 1201 North Market Street
- Suite 111
- Wilmington, DE 19801
- United States
Corporate Office
- 1201 North Market Street
- Suite 111
- Wilmington, DE 19801
- United States
NRx Pharmaceuticals Timeline
NRx Pharmaceuticals Stock Performance
As of 12-Nov-2026, NRx Pharmaceuticals’s stock price is $2.27. Its current market cap is $100M with 43.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.27 | $2.44 | $1.62 - $5.05 | $100M | 43.6M | 1.03M | -$0.58 |
NRx Pharmaceuticals Financials Summary
As of 30-Jun-2026, NRx Pharmaceuticals has a trailing 12-month revenue of $3.39M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 169,275 | 83,454 | 31,630 | 40,347 |
| Revenue | 3,394 | 1,225 | 0 | 0 |
| EBITDA | (21,875) | (27,820) | (24,935) | (30,519) |
| Net Income | (23,480) | (28,622) | (25,126) | (30,150) |
| Total Assets | 34,160 | 12,956 | 3,651 | 7,315 |
| Total Debt | 1,246 | 631 | 6,577 | 9,161 |
NRx Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NRx Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
NRx Pharmaceuticals Comparisons
Industry
Financing
Details
NRx Pharmaceuticals Competitors (6)
One of NRx Pharmaceuticals’s 6 competitors is Intracellular Therapies, a Formerly VC-backed company based in Bedminster, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intracellular Therapies | Formerly VC-backed | Bedminster, NJ | ||||
| Relmada Therapeutics | Formerly VC-backed | Coral Gables, FL | ||||
| Axsome Therapeutics | Formerly VC-backed | New York, NY | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
NRx Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NRx Pharmaceuticals Patents
NRx Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260345519-A1 | Parenteral ketamine formulations and methods thereof | Pending | 02-May-2025 | ||
| WO-2026232044-A1 | Parenteral ketamine formulations and methods thereof | Pending | 02-May-2025 | ||
| US-10583138-B2 | Composition and method for treatment of depression and psychosis in humans | Active | 12-Jul-2012 | ||
| US-20180263976-A1 | Composition and method for treatment of depression and psychosis in humans | Active | 12-Jul-2012 | A61K31/496 |
NRx Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NRx Pharmaceuticals Acquisitions (3)
NRx Pharmaceuticals’s most recent deal was a Merger/Acquisition with GeNeuro. The deal was made on 18-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GeNeuro | 18-May-2026 | Merger/Acquisition | Biotechnology | ||
| Kadima Neuropsychiatry Institute | 13-May-2025 | Merger/Acquisition | Practice Management (Healthcare) | ||
| Big Rock Partners Acquisition | 24-May-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
NRx Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
NRx Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HOPE Therapeutics | Wilmington, DE | 2023 |
NRx Pharmaceuticals FAQs
-
When was NRx Pharmaceuticals founded?
NRx Pharmaceuticals was founded in 2015.
-
Where is NRx Pharmaceuticals headquartered?
NRx Pharmaceuticals is headquartered in Wilmington, DE.
-
What is the size of NRx Pharmaceuticals?
NRx Pharmaceuticals has 29 total employees.
-
What industry is NRx Pharmaceuticals in?
NRx Pharmaceuticals’s primary industry is Drug Discovery.
-
Is NRx Pharmaceuticals a private or public company?
NRx Pharmaceuticals is a Public company.
-
What is NRx Pharmaceuticals’s stock symbol?
The ticker symbol for NRx Pharmaceuticals is NRXP.
-
What is the current stock price of NRx Pharmaceuticals?
As of 12-Nov-2026 the stock price of NRx Pharmaceuticals is $2.27.
-
What is the current market cap of NRx Pharmaceuticals?
The current market capitalization of NRx Pharmaceuticals is $100M.
-
What is NRx Pharmaceuticals’s current revenue?
The trailing twelve month revenue for NRx Pharmaceuticals is $3.39M.
-
Who are NRx Pharmaceuticals’s competitors?
Intracellular Therapies, Relmada Therapeutics, Axsome Therapeutics, Pfizer Pakistan, and Pfizer (Vienna) are some of the 6 competitors of NRx Pharmaceuticals.
-
What is NRx Pharmaceuticals’s annual earnings per share (EPS)?
NRx Pharmaceuticals’s EPS for 12 months was -$0.58.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
